ALLERGAN INC 4
4 · ALLERGAN INC · Filed Jul 6, 2005
Insider Transaction Report
Form 4
ALLERGAN INC(AGN)
EVANS HANDEL
Director
Transactions
- Award
Phantom Stock Units
2005-06-08$82.20/sh+33.8$2,778→ 27,817.08 total→ Common Stock (0 underlying) - Award
Phantom Stock Units
2005-07-01$84.62/sh+88.63$7,500→ 27,905.71 total→ Common Stock (0 underlying) - Award
Phantom Stock Units
2005-07-01$84.62/sh+29.54$2,500→ 27,935.25 total→ Common Stock (0 underlying)
Footnotes (4)
- [F1]Converts to common stock on a 1-for-1 basis.
- [F2]Phantom stock units accrued under the Allergan, Inc. Dividend Reinvestment Plan, exempt transaction under Rule 16a-11.
- [F3]Phantom stock units are to be settled 100% in stock upon the reporting person's retirement as an Allergan, Inc. director.
- [F4]Phantom stock units acquired under the Allergan, Inc. Deferred Directors' Fee Program in lieu of cash for quarterly portion of annual retainer.